These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27079776)

  • 1. Bipolar depression: Managing patients with second generation antipsychotics.
    Avery LM; Drayton SJ
    Int J Psychiatry Med; 2016; 51(2):145-59. PubMed ID: 27079776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of bipolar depression: making sensible decisions.
    Citrome L
    CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review and Network Meta-analysis: Efficacy and Safety of Second-Generation Antipsychotics in Youths With Bipolar Depression.
    DelBello MP; Kadakia A; Heller V; Singh R; Hagi K; Nosaka T; Loebel A
    J Am Acad Child Adolesc Psychiatry; 2022 Feb; 61(2):243-254. PubMed ID: 34420839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical highlights in bipolar depression: focus on atypical antipsychotics.
    Calabrese JR; Elhaj O; Gajwani P; Gao K
    J Clin Psychiatry; 2005; 66 Suppl 5():26-33. PubMed ID: 16038599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Second generation antipsychotics in bipolar depression: a new therapeutic option?].
    Llorca PM
    Encephale; 2011 Dec; 37 Suppl 3():S209-13. PubMed ID: 22212877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of FDA-approved treatment options in bipolar depression.
    McIntyre RS; Cha DS; Kim RD; Mansur RB
    CNS Spectr; 2013 Dec; 18 Suppl 1():4-20; quiz 21. PubMed ID: 24237641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotics as antidepressants.
    Roberts RJ; Lohano KK; El-Mallakh RS
    Asia Pac Psychiatry; 2016 Sep; 8(3):179-88. PubMed ID: 25963405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics.
    Selle V; Schalkwijk S; Vázquez GH; Baldessarini RJ
    Pharmacopsychiatry; 2014 Mar; 47(2):43-52. PubMed ID: 24549862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a conventional mood stabilizer alone or in combination with second-generation antipsychotics on recurrence rate and discontinuation rate in bipolar I disorder in the maintenance phase: A systematic review and meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Sakuma K; Okuya M; Matsuda Y; Esumi S; Hashimoto Y; Hatano M; Miyake N; Miura I; Mishima K; Iwata N
    Bipolar Disord; 2021 Dec; 23(8):789-800. PubMed ID: 33561884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-Generation Antipsychotics in Management of Acute Pediatric Bipolar Depression: A Systematic Review and Meta-analysis.
    Patel RS; Veluri N; Patel J; Patel R; Machado T; Diler R
    J Child Adolesc Psychopharmacol; 2021 Oct; 31(8):521-530. PubMed ID: 34665020
    [No Abstract]   [Full Text] [Related]  

  • 12. Bipolar depression: the role of atypical antipsychotics.
    Post RM; Calabrese JR
    Expert Rev Neurother; 2004 Nov; 4(6 Suppl 2):S27-33. PubMed ID: 16279863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
    Cruz N; Sanchez-Moreno J; Torres F; Goikolea JM; Valentí M; Vieta E
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):5-14. PubMed ID: 19638254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine-fluoxetine combination for the treatment of bipolar depression.
    Citrome L
    Expert Opin Pharmacother; 2011 Dec; 12(17):2751-8. PubMed ID: 22035291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Important clinical features of atypical antipsychotics in acute bipolar depression that inform routine clinical care: a review of pivotal studies with number needed to treat.
    Gao K; Yuan C; Wu R; Chen J; Wang Z; Fang Y; Calabrese JR
    Neurosci Bull; 2015 Oct; 31(5):572-88. PubMed ID: 26024955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bipolar depression: a new role for atypical antipsychotics?
    Keck PE
    Bipolar Disord; 2005; 7 Suppl 4():34-40. PubMed ID: 15948765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorder.
    Atkin T; Nuñez N; Gobbi G
    J Child Psychol Psychiatry; 2017 Aug; 58(8):865-879. PubMed ID: 28474733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of lurasidone for bipolar depression.
    Loebel A; Xu J; Hsu J; Cucchiaro J; Pikalov A
    Ann N Y Acad Sci; 2015 Nov; 1358():95-104. PubMed ID: 26771990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.